(Press-News.org) Researchers at the University of Connecticut have found a new way to identify protein mutations in cancer cells. The novel method is being used to develop personalized vaccines to treat patients with ovarian cancer.
"This has the potential to dramatically change how we treat cancer," says Dr. Pramod Srivastava, director of the Carole and Ray Neag Comprehensive Cancer Center at UConn Health and one of the principal investigators on the study. "This research will serve as the basis for the first ever genomics-driven personalized medicine clinical trial in immunotherapy of ovarian cancer, and will begin at UConn Health this fall," Srivastava says.
UConn bioinformatics engineer Ion Mandoiu, associate professor of computer science and engineering, collaborated as the other principal investigator for the study, which has been in development for the past four years. The results appear online in the 22 September issue of the Journal of Experimental Medicine.
Dr. Angela Kueck, a gynecological oncologist at UConn Health, will run the initial clinical study, once it is approved by the FDA. The research team will sequence DNA from the tumors of 15 to 20 women with ovarian cancer, and use that information to make a personalized vaccine for each woman.
The researchers focused their clinical trial on patients with ovarian cancer because the disease usually responds well to surgery and chemotherapy in the short term, but often returns lethally within a year or two. That gives researchers the perfect window to prepare and administer the new therapeutic vaccines, and also means they may be able to tell within two years or so whether the vaccine made a difference. If the personalized vaccines prove to be safe and feasible, they'll design a Phase II trial to test its clinical effectiveness by determining whether they prolong patients' lives.
Identifying tiny differences
In order for the immune system to attack cancers, it first has to recognize them. Every cell in the body has a sequence of proteins on its exterior that acts like an ID card or secret handshake, confirming that it's one of the good guys. These protein sequences, called epitopes, are what the immune system 'sees' when it looks at a cell. Cancerous cells have epitopes, too. Since cancer cells originate from the body itself, their epitopes are very similar to those of healthy cells, and the immune system doesn't recognize them as bad actors that must be destroyed.
But just as even the best spy occasionally slips up on the details, cancer cell epitopes have tiny differences or mistakes that could give them away, if only the immune system knew what to look for.
"We want to break the immune system's ignorance," Srivastava says. For example, there could be 1,000 subtle changes in the cancer cell epitopes, but only 10 are "real," meaning significant to the immune system. To find the real, important differences, Mandoiu, the bioinformatics engineer, took DNA sequences from skin tumors in mice and compared them with DNA from the mice's healthy tissue.
Previous researchers had done this but looked at how strongly the immune system cells bound to the cancer's epitopes. This works when making vaccines against viruses, but not for cancers. Instead, Srivastava's team came up with a novel measure: they looked at how different the cancer epitopes were from the mice's normal epitopes. And it worked. When mice were inoculated with vaccines made of the cancer epitopes differing the most from normal tissue, they were very resistant to skin cancer.
Theoretically, this approach could work for other cancers, although the research has yet to be done.
Researchers in cancer biology, immunology, and computational bioinformatics had to work together to discover these connections. This type of collaboration is the engine driving UConn's personalized medicine and genomics research, according to UConn's vice president for research, Jeffrey Seemann.
"This research is a great example of how diverse disciplines create synergy under the umbrella of genomics," Seemann says. "UConn aims to capitalize on such synergies to make progress in many areas that tap into the genomics realm."
UConn researchers have applied for two patents for their new technique, and a Connecticut start-up company, Accuragen Inc., in which Srivastava has a financial interest, has obtained an option to license the patents.
Creating a safe, effective cancer vaccine is one of the major long-term goals of personalized medicine. Using a different approach than the one described in this paper, Srivastava's research has already created a vaccine against kidney cancer, which is in clinical use and commercially available in Russia.
"It is known that patients have genetic sequences that make them better candidates for some drugs than others. And we can figure that out much more easily now than five years ago," Srivastava says. The novelty of Srivastava's approach in this new research is that it results in a drug specifically designed for a single person. If the approach proves safe and effective, it would be the ultimate in individualized medicine.
INFORMATION:
Antibiotic-resistant bacteria can share resources to cause chronic infections, Vanderbilt University investigators have discovered. Like the individual members of a gang who might be relatively harmless alone, they turn deadly when they get together with their "friends."
The findings, reported Oct. 8 in Cell Host & Microbe, shed light on a long-standing question in infectious diseases and may inform new treatment strategies, said Eric Skaar, Ph.D., MPH, Ernest W. Goodpasture Professor of Pathology, Microbiology and Immunology.
One way that Staphylococcus aureus and other ...
Using the NASA/ESA Hubble Space Telescope astronomers have made what may be the most reliable distance measurement yet of an object that existed in the Universe's formative years. The galaxy is one of the faintest, smallest and most distant galaxies ever seen and measuring its distance with this accuracy was possible due only to the incredibly detailed mapping of how giant galaxy clusters warp the space-time around them.
Astronomers often use gravitational lensing -- the magnifying power of galaxy clusters -- to find distant galaxies [1]. However, when it comes to the ...
Boulder, Colo., USA - What is the "Sixth Extinction"? How do paleontologists determine North America's future fire threats? What do trilobites look like on the inside? Did the Chicxulub impact trigger an eruption? Here, the Paleontological Society highlights some of the best science and current work in paleontology to be presented at the 126th Annual Meeting of The Geological Society of America on 19-22 October in Vancouver, BC, Canada.
SUNDAY, 18 Oct.
Geospatial Analysis of Human-Megafaunal Overlap in North America: Lead author Meaghan Emery and colleagues write that ...
Organisms ranging from bacteria to humans have circadian clocks to help them synchronize their biological activities to the time of day. A study published by Cell Press October 16th in Cell now reveals that gut microbes in mice and humans have circadian rhythms that are controlled by the biological clock of the host in which they reside. Disruption of the circadian clock in the host alters the rhythms and composition of the microbial community, leading to obesity and metabolic problems.
"These findings provide an explanation for a long-standing and mysterious observation, ...
Supplementing the diet with omega-6 polyunsaturated fatty acids has beneficial effects on heart health by lowering "bad" LDL cholesterol and raising "good" HDL cholesterol, but the underlying mechanisms involved are poorly understood. Now research based on the genetic information from over 100,000 individuals of European ancestry has uncovered a gene that affects blood cholesterol levels through the generation of a compound from omega-6 polyunsaturated fatty acids, called lipoxins. The study, publishing online October 16 in the Cell Press journal Cell Metabolism, also provides ...
Researchers have found that male and female brains respond in remarkably different ways to high-fat meals. Those differences in the brain lead to greater inflammation and increased health risks in males that indulge on fatty foods in comparison to females, a new study in mice shows. The findings reported in the Cell Press journal Cell Reports on October 16th may help to explain observed differences in obesity outcomes between women and men – premenopausal women carrying extra weight fare better than men do – and suggest that dietary advice should be made more ...
Two closely related viruses that have been introduced to northern Spain in recent years have already led to the collapse of three different species of amphibian—the common midwife toad, the common toad, and the alpine newt—in the protected area of Picos de Europa (literally "Peaks of Europe") National Park. In all, six amphibian species have suffered from severe disease and mass mortality as a result of the outbreak, and researchers who report their findings in the Cell Press journal Current Biology on October 16 say that the viruses appear to be on the move. ...
Scientists tracing the real-time impact of viruses in the wild have found that entire amphibian communities are being killed off by closely related viruses introduced to mountainous areas of northern Spain.
Researchers from UCL, Zoological Society of London (ZSL) and Queen Mary University of London (QMUL) in the UK, and the National Museum of Natural Sciences (MNCN-CSIC) in Madrid, Spain found the viruses are causing severe disease and mass deaths in many amphibian species sampled, including frogs and salamanders. The common midwife toad, common toad and alpine newt ...
A newly discovered population of immune cells in tumors is associated with less severe cancer outcomes in humans, and may have therapeutic potential, according to a new UC San Francisco study of 3,600 human tumors of 12 types, as well as mouse experiments.
The research is published online October 16, 2014 in the journal Cancer Cell.
Molecules associated with these cells, newly identified by the UCSF researchers, could be the focus of new immunotherapies that are more precisely targeted than current immunotherapies now in clinical trials, said Matthew Krummel, PhD, professor ...
Choosing between two good things can be tough. When animals must decide between feeding and mating, it can get even trickier. In a discovery that might ring true even for some humans, researchers have shown that male brains – at least in nematodes – will suppress the ability to locate food in order to instead focus on finding a mate.
The results, which appear today in the journal Current Biology, may point to how subtle changes in the brain's circuitry dictate differences in behavior between males and females.
"While we know that human behavior is influenced ...
